Benzyl benzoate emulsion for external use 20% 200 g
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Benzyl benzoate
Release form
Emulsion
Composition
Emulsion for external use of 20% 1 g benzyl benzoate 200 mg
Pharmacological effect
Pharmacokinetics
Indications
Antiparasitic agent for external use. Active against scabby mites, as well as lice. Under the action of benzyl benzoate, the death of scabby mites occurs in 7-32 minutes, lice - in 2-5 hours.
Use during pregnancy and lactation
Possible: allergic reactions.
Side effects
During the treatment period, exacerbation of psoriasis is possible. With pheochromocytoma, propranolol can be used only after taking an alpha blocker. After a long course of treatment, propranolol should be discontinued gradually, under the supervision of a physician. Against the background of treatment with propranolol, IV administration of verapamil, diltiazem should be avoided. A few days before anesthesia, you must stop taking propranolol or pick up a remedy for anesthesia with minimal negative inotropic effects. Influence on the ability to drive vehicles and control mechanisms In patients whose activities require increased attention, the question of the use of propranolol on an outpatient basis should be addressed only after evaluating the individual response of the patient.
special instructions
During the treatment period, exacerbation of psoriasis is possible. With pheochromocytoma, propranolol can be used only after taking an alpha blocker. After a long course of treatment, propranolol should be discontinued gradually, under the supervision of a physician. Against the background of treatment with propranolol, IV administration of verapamil, diltiazem should be avoided. A few days before anesthesia, you must stop taking propranolol or pick up a remedy for anesthesia with minimal negative inotropic effects. Influence on the ability to drive vehicles and control mechanisms In patients whose activities require increased attention, the question of the use of propranolol on an outpatient basis should be addressed only after evaluating the individual response of the patient.